How Boehringer, Lilly Are Taming The GenAI Dragon For Regulatory, Commercial Content
Open AI's GPT-4 A Hit Among Users
Heads of AI, global commercial services and human pharma services at Boehringer and Eli Lilly discuss at a recent summit ways to use generative AI like ChatGPT for commercial and regulatory content while tackling challenges like data protection, hallucination and CXO buy-in
